Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

26.17
Delayed Data
As of Sep 23
 +0.15 / +0.58%
Today’s Change
9.51
Today|||52-Week Range
26.36
+94.72%
Year-to-Date
Seeing the Same Old Patterns Ahead of Fed News
Sep 19 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close26.02
Today’s open26.02
Day’s range25.64 - 26.23
Volume511,207
Average volume (3 months)566,953
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+150.00%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+18.34%
P/E ratio52.3
Price/Sales4.76
Price/Book10.79

Competitors

 Today’s
change
Today’s
% change
CEMPCempra Inc+0.61+2.48%
PTLAPortola Pharmaceutic...-0.52-2.19%
INVAInnoviva Inc+0.01+0.09%
TXMDTherapeuticsMD Inc+0.15+2.40%
Data as of 4:00pm ET, 09/23/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)$0.19
Annual revenue (last year)$144.4M
Annual profit (last year)$14.0M
Net profit margin9.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

Search for Jobs